OncoMatch/Clinical Trials/NCT07257679

Gentle Touch for Post-Mastectomy Lymphedema

Is NCT07257679 recruiting? Yes, currently enrolling (May 2026). This Phase 4 trial studies non-drug interventions for lymphedema, breast cancer.

Phase 4RecruitingI.R.C.C.S. Fondazione Santa LuciaNCT07257679Data as of May 2026

This is a single-blind, parallel-group Randomized Controlled Trial (RCT) comparing the efficacy of a specialized manual technique, Gentle Touch (GT), versus a control intervention, both added to the usual rehabilitative care. The study investigates 36 women aged 30 to 75 with Breast Cancer-Related Lymphedema (BCRL). The primary objective is to evaluate the reduction of lymphedema volume in the upper limb. Secondary objectives include assessing the improvement in patients' quality of life and the potential reduction in care burden and costs. The treatment protocol involves 10 bi-weekly sessions over 5 weeks.

Check if I qualify

Extracted eligibility criteria

Cancer type

Breast Carcinoma

Prior therapy

Must have received: surgery

Women who have undergone surgery for breast cancer (BC). This includes being subjected to one of the following interventions: Axillary dissection with removal of all 3 lymph node levels; Axillary dissection with removal of only one lymph node level; Removal of the sentinel lymph node only.

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify